Sparrow Pharmaceuticals, Inc. announced it raised $1.08 Million in an initial filing from an offering of $50.8 Million
Sparrow Pharmaceuticals, Inc. announced it raised $1.08 Million in an initial filing from an offering of $50.8 Million
01/13/21, 7:09 PM
Location
portlandMoney raised
$1.08 million
Industry
healthcare
Round Type
seed
Company Info
Location
1050 southwest 6th street, suite 1100
portland, oregon, united states
Additional Info
Sparrow Pharmaceuticals is developing targeted therapies for conditions of corticosteroid excess - associated with either the natural corticosteroid cortisol due to a tumor or long-term use of a corticosteroid drug such as prednisone. Sparrow's pipeline is led by SPI-62 in Phase 2 clinical development.